Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune modulation by mesenchymal stem cells.

Ida Rasmusson1

  • 1Division of Clinical Immunology F79, Huddinge University Hospital, SE-141 86 Stockholm, Sweden. Ida.Rasmusson@ki.se

Experimental Cell Research
|April 25, 2006
PubMed
Summary

Mesenchymal stem cells (MSCs) suppress T cell activation in vivo and in vitro. This immune modulation is crucial for maintaining homeostasis and preventing rejection in specific environments, though the exact mechanisms require further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization.

Diabetes·2008
Same author

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes.

Journal of leukocyte biology·2007
Same author

Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

Transplantation·2006
Same author

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.

Experimental cell research·2005
Same author

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Lancet (London, England)·2004
Same author

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.

Transplantation·2003

Area of Science:

  • Immunology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Mesenchymal stem cells (MSCs) exhibit potent immunosuppressive properties.
  • MSC-mediated immune suppression is observed both in laboratory settings (in vitro) and within living organisms (in vivo).
  • This immunosuppression is relevant for physiological processes like maintaining bone marrow homeostasis and maternal-fetal tolerance.

Purpose of the Study:

  • To elucidate the role of Mesenchymal stem cells (MSCs) in modulating immune responses.
  • To understand how MSCs influence key immune cells involved in recognizing and eliminating foreign antigens.
  • To investigate the underlying molecular mechanisms of MSC-induced immunosuppression.

Main Methods:

  • Studies were conducted both in vivo and in vitro.
  • The impact of MSCs on antigen-presenting cells, T cells, and natural killer cells was assessed.
  • Analysis focused on immune cell activation and function.

Main Results:

  • Mesenchymal stem cells (MSCs) effectively suppress T cell activation.
  • MSCs modulate the function of antigen-presenting cells, T cells, and natural killer cells.
  • Evidence suggests MSCs play a role in immune privilege sites.

Conclusions:

  • Mesenchymal stem cells (MSCs) are significant immune modulators.
  • MSC immunosuppression is vital for immune homeostasis and specific physiological contexts.
  • Further research is needed to fully understand the molecular basis of MSC immunosuppressive effects.

Related Experiment Videos